RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
Thromb Haemost 1987; 58(04): 1093
DOI: 10.1055/s-0038-1646062
DOI: 10.1055/s-0038-1646062
Letter to the Editor
Antithrombin III in Patients with Hepatocellular Carcinoma
Weitere Informationen
Publikationsverlauf
Received 16. Juni 1987
Accepted after revision 17. August 1987
Publikationsdatum:
29. Juni 2018 (online)
-
References
- 1 Aurousseau MH, D’Angeli JL, Josso F. Antithrombin III versus prothrombin in liver cirrhosis. Haemostasis 1981; 10: 104-107
- 2 Chan V, Lai CL, Chan TK. Metabolism of antithrombin III in cirrhosis and carcinoma of the liver. Clin Science 1981; 60: 681-688
- 3 Boneu B, Sie P, Caranobe C, Cassigneul J, Pascal J. Progressive antithrombin activity and the concentration of three inhibitors in liver cirrhosis. Thromb Haemostas 1982; 47: 78
- 4 Knot E, ten Cate JW, Drijfhout HR, Kahle LH, Tytgat GN. Antithrombin III metabolism in patients with liver disease. J Clin Pathol 1984; 37: 523-530
- 5 Rodzynek J JR, Preux C, Leautaud P, Abramovici J, Di Paolo A, Delcourt AA. Diagnostic value of antithrombin III and aminopyrine breath test in liver disease. Arch Intern Med 1986; 146: 677-680
- 6 Leone G, Cotumaccio R, De Stefano V, Zanetti L, Bizzi B. Different forms of AT III congenital defect: a study by crossed immunoelec-trofocusing. Scand J Haematol 1984; 33: 410-417
- 7 Fair DS, Bahnak BR. Human hepatoma cells secrete single chain Factor X, Prothrombin, and Antithrombin ill. Blood 1984; 64: 194-204